LEP and endometrial cancer: Hyperinsulinaemia, leptin, aromatase activation and 17-β-oestradiol synthesis in WAT CLS drive the increased incidence of oestrogen-sensitive cancers in women with obesity (postmenopausal breast cancer, endometrial cancer, ovarian, thyroid cancer).